1776 Wealth’s AbbVie ABBV Stock Holding History

1776 Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Hold	1,021	–	–	0.09%	133
2026 Q1	$222K	Hold	1,021	–	–	0.09%	139
2025 Q4	$233K	Hold	1,021	–	–	0.09%	132
2025 Q3	$236K	Buy	+1,021	New	+$208K	0.09%	133
2025 Q2	–	Sell	-1,226	Closed	-$257K	–	144
2025 Q1	$257K	Buy	+1,226	New	+$238K	0.12%	126
2024 Q4	–	Sell	-1,226	Closed	-$242K	–	139
2024 Q3	$242K	Buy	+1,226	New	+$229K	0.11%	132
2022 Q2	–	Sell	-1,415	Closed	-$229K	–	121
2022 Q1	$229K	Buy	+1,415	New	+$206K	0.13%	114
2020 Q3	–	Sell	-1,510	Closed	-$148K	–	113
2020 Q2	$148K	Sell	1,510 -590	-28%	-$51.9K	0.1%	116
2020 Q1	$171K	Buy	2,100 +1,100	+110%	+$93.7K	0.07%	149
2019 Q4	$88K	Buy	+1,000	New	+$83K	0.07%	146

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

1776 Wealth's ABBV Position: Q2 2026 in Review

1776 Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 1,021 shares worth $257K. The position accounts for 0.09% of the portfolio, ranked #133.

1776 Wealth first reported a position in ABBV in Q4 2019 and has held it in 10 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

1776 Wealth held 1,021 shares of AbbVie worth $257K as of Q2 2026.
1776 Wealth left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.09% of 1776 Wealth's portfolio in Q2 2026, its #133 holding.
1776 Wealth first reported a position in AbbVie in Q4 2019 and has held it in 10 quarters since.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 1776 Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.